| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |